Abstract: Apparatus is described including a sensing electrode that detects electrical activity of a duodenum of a subject. The apparatus includes a control unit configured to facilitate a treatment of the subject responsively to the detected electrical activity. Other embodiments are also described.
Type:
Grant
Filed:
July 24, 2008
Date of Patent:
October 7, 2014
Assignee:
Betastim, Ltd.
Inventors:
Yossi Gross, Yossi Roffeh, Radwin Khawaled, Jacob Benarie
Abstract: A method is provided, including placing first and second electrodes at respective first and second sites of a duodenum of a subject, and activating the electrodes to increase a blood insulin level of the subject. Other embodiments are also described.
Type:
Application
Filed:
December 15, 2011
Publication date:
April 5, 2012
Applicant:
BETASTIM, LTD.
Inventors:
Yossi Gross, Jacob Benarie, Radwan Khawaled, Ruth Alon
Abstract: A method is provided, including placing first and second electrodes (90) at respective first and second sites of a duodenum (40) of a subject, and activating the electrodes (90) to increase a blood insulin level of the subject. Other embodiments are also described.
Type:
Grant
Filed:
July 13, 2006
Date of Patent:
January 10, 2012
Assignee:
Betastim, Ltd.
Inventors:
Yossi Gross, Jacob Benarie, Radwan Khawaled, Ruth Alon
Abstract: Apparatus is provided, including an ingestible capsule, one or more electrodes coupled to the capsule, and a control unit configured to maintain the capsule in a vicinity of a designated site of a subject by driving at least a subset of the electrodes to apply a current that induces reverse intestinal peristalsis in the subject. Other embodiments are also described.
Type:
Grant
Filed:
June 13, 2008
Date of Patent:
April 12, 2011
Assignee:
Betastim, Ltd.
Inventors:
Radwan Khawaled, Jacob Benarie, Yossi Gross
Abstract: Apparatus is provided, including a control unit configured for implantation in a body of a subject. An electrode is coupled to the control unit. The control unit is configured to receive programming instructions via the electrode and to drive current into tissue of the subject via the electrode. Other embodiments are also described.
Abstract: Apparatus (21) is described including a sensing electrode (22) that detects electrical activity of a duodenum (26) of a subject. The apparatus (21) includes a control unit (20) configured to facilitate a treatment of the subject responsively to the detected electrical activity. Other embodiments are also described.
Type:
Application
Filed:
July 24, 2008
Publication date:
November 25, 2010
Applicant:
BETASTIM, LTD.
Inventors:
Yossi Gross, Yossi Roffeh, Radwin Khawaled, Jacob Benarie
Abstract: Apparatus is provided, including a control unit configured for implantation in a body of a subject. An electrode is coupled to the control unit. The control unit is configured to receive programming instructions via the electrode and to drive current into tissue of the subject via the electrode. Other embodiments are also described.
Abstract: A method is provided, including placing first and second electrodes (90) at respective first and second sites of a duodenum (40) of a subject, and activating the electrodes (90) to increase a blood insulin level of the subject. Other embodiments are also described.
Type:
Application
Filed:
July 13, 2006
Publication date:
March 5, 2009
Applicant:
Betastim, Ltd.
Inventors:
Yossi Gross, Jacob Benarie, Radwan Khawaled, Ruth Alon
Abstract: Apparatus is provided, including an ingestible capsule, one or more electrodes coupled to the capsule, and a control unit configured to maintain the capsule in a vicinity of a designated site of a subject by driving at least a subset of the electrodes to apply a current that induces reverse intestinal peristalsis in the subject. Other embodiments are also described.
Type:
Application
Filed:
June 13, 2008
Publication date:
January 29, 2009
Applicant:
Betastim, Ltd.
Inventors:
Radwan Khawaled, Jacob Benarie, Yossi Gross
Abstract: A method is provided, including placing first and second electrodes at respective first and second sites of a duodenum of a subject, and activating the electrodes to increase a blood insulin level of the subject. Other embodiments are also described.
Type:
Application
Filed:
April 11, 2006
Publication date:
January 18, 2007
Applicant:
BETASTIM, LTD.
Inventors:
Yossi Gross, Jacob Benarie, Radwin Khawaled, Ruth Alon